Technology Opportunities

BGN (42)
BioRap (8)
BIRAD (5)
Mor (5)
Technion (25)
Tel Hashomer (13)
Refine / Revise Search98 technologies found
page 1 of 5
A method for Evaluating A Mental Disorder (BGN)
Scientific Contact: Claude Brodski
More Details...
A Method of Treating Neurodegenerative Diseases (BGN)
Scientific Contact: Alon Monsonego
More Details...
A Novel Alginate Hydrogel Based Controlled and Targeted Delivery System (BGN)
Controlled drug delivery systems offer numerous advantages compared to conventional dosage forms including improved efficacy, reduced toxicity, and improved patient compliance and convenience. Controlled release systems aim to improve the effectiveness of drug therapy. This improvement can take ...
Scientific Contact: Smadar Cohen
More Details...
A Novel Hydrogel Based Injectable Bilayer Device for Simultaneous Regeneration of Articular Cartilage and Subchondral Bone (BGN)
A subchondral defect is usually characterized by a structural breakdown of the articular cartilage and the bone underneath due to trauma or disease, leading to chronic disabilities. Treating such defects is an important medical target since in the adult patient, damaged cartilage cannot ...
Scientific Contact: Smadar Cohen
More Details...
A Novel Non-Hormonal Composition as Contraceptive for Ovulation (Tel Hashomer)
A Novel Non-Hormonal Composition as Contraceptive for Ovulation Ariel Hourvitz, Yuval Yung, Svetlana Markman and Gil Yerushalmi, Sheba Medical Center Categories Women Health , Contraceptive Composition, Fertility, Non Hormonal Development Stage Preclinical studies – efficacy and ...
More Details...
A Novel Non-Hormonal Composition as Contraceptive for Ovulation (Tel Hashomer)
A Novel Non-Hormonal Composition as Contraceptive for Ovulation Ariel Hourvitz, Yuval Yung, Svetlana Markman and Gil Yerushalmi, Sheba Medical Center Categories Women Health , Contraceptive Composition, Fertility, Non Hormonal Development Stage Preclinical studies – efficacy and ...
More Details...
A novel strategy for treating melanoma development and resistance (Technion)
The present technology describes the caspase-3/YAP module as a new target for the treatment of melanoma development and ...
More Details...
A Novel Treatment for Leaking Blebs (Mor)
Background Glaucoma is a disease characterized by intra-ocular pressure sufficient to damage the optic nerve and cause permanent impairment of vision. Glaucoma is rarely cured, but its progression can be greatly delayed by reducing the intra-ocular pressure with medicines, laser procedure or ...
Scientific Contact: Orna Geyer
More Details...
A pharmacological Trojan horse approach to eradicate multidrug-resistant cancer (Technion)
The present technology describes an efficient method to eradicate multidrug resistance (MDR) tumor cells via lysosomal photodestruction ...
More Details...
Acyl-Coa: Diacylglycerol Acyltransferase 1-like Gene (PTDGAT1) and Uses Thereof (BGN)
Scientific Contact: Sammy Boussiba
More Details...
Alginate Biomaterials for Treating Liver Dysfunction and Disease (BGN)
Acute liver failure and chronic liver disease, such as hepatitis and cirrhosis, present a huge unmet medical need, with annual 1-2 million deaths worldwide. The liver is responsible for detoxification-removing and excreting body wastes and hormones, drugs and foreign substances, synthesis of plasma ...
Scientific Contact: Smadar Cohen
More Details...
Amphiphilic Peptides and Matrices for Treatment of Osteoporosis (BGN)
Scientific Contact: Hanna Rapaport
More Details...
Amyloid Beta-Peptides and Methods of Use Thereof (BGN)
Scientific Contact: Alon Monsonego
More Details...
An Expeditious Synthesis of Ubiquitinated Peptide Conjugates (BGN)
Scientific Contact: Ashraf Brik
More Details...
An Innovative Therapy for Inflammatory Diseases (BGN)
Inflammation often named “the secret killer” is a key factor in a large group of diseases affecting and killing millions of people every year. Examples of inflammatory diseases or diseases with key inflammatory components include Arthritis, Alzheimer, Parkinson, ALS, Peritonitis, Colitis, ...
Scientific Contact: Rachel Levy
More Details...
Anti-Hepatitis C virus neutralizing antibodies (BIRAD)
The ProblemHCV is a major public health problem, with over 185 million people infected worldwide and at risk for developing life-threatening liver disease. Although FDA approved several Direct-Acting Antiviral Drugs (DAAs) demonstrating high efficacy and safety, they are highly expensive and ...
Scientific Contact: Meital Gal-Tanamy
More Details...
BENoC-bus enhancement network on chip (Technion)
Network on chip (NoC) is the future of VLSI interconnects. The technology enables improved chip performance in numerous aspects such as power consumption and data transfer rate. Several drawbacks are to be worked out to accelerate its acceptance as an industry standard. Our technology solves some ...
More Details...
BioGAL - Novel use of Erythropoietin (EPO) for the treatment of Multiple Myeloma (Mor)
Background MM is a severe and incurable plasma cell malignancy and the second most common blood cancer. The median survival of untreated patients is approximately 10 months. Aggressive chemotherapy may prolong life to an average of 15-40 months. No cure has been found for MM. There is an unmet ...
Scientific Contact: Moshe Mittelman
More Details...
Casein micelles for encapsulation of hydrophobic compounds (Technion)
The present technology presents a novel harness casein-micelles (CM), which are natural nanocapsules of essential nutrients for the neonate, by incorporating nutraceuticals in their ...
More Details...
Casein particles encapsulating therapeutically active agents. (Technion)
The present technology describes a novel oral drug delivery system for drug resistance gastric cancers. Comprising a hydrophobic chemotherapeutic drug and a chemosensitizer entrapped within nanoparticles of beta casein (β-CN), which self-associates into micelles. ...
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.